Treace Medical Concepts, Inc. (TMCI) Financials
TMCI Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 251.9 million | 114.0 million |
2023-09-30 | 240.4 million | 102.5 million |
2023-06-30 | 249.6 million | 99.7 million |
2023-03-31 | 249.2 million | 91.6 million |
TMCI Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -1.7 million | 5.9 million |
2023-09-30 | -13.0 million | 5.2 million |
2023-06-30 | -12.6 million | 3.6 million |
2023-03-31 | -18.7 million | 2.7 million |
TMCI Net Income
No data available :(
TMCI Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 123.2 million | - | 17.3 million |
2023-09-30 | 122.2 million | - | 17.6 million |
2023-06-30 | 139.5 million | - | 16.8 million |
2023-03-31 | 170.7 million | 52.8 million | 16.5 million |
TMCI Shares Outstanding
TMCI Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 2.2 million | 4.2 million | 13.4 million | 39.9 million |
2023-09-30 | 3.5 million | 4.4 million | 12.7 million | 33.5 million |
2023-06-30 | 4.2 million | 3.5 million | 10.0 million | 33.8 million |
2023-03-31 | 1.5 million | 3.4 million | 10.9 million | 33.7 million |
TMCI Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 62.2 million | 11.5 million |
2023-09-30 | 40.8 million | 8.0 million |
2023-06-30 | 42.0 million | 7.7 million |
2023-03-31 | 42.2 million | 8.0 million |
TMCI
Price: $11.21
52 week price:
Earnings Per Share: -0.81 USD
P/E Ratio: -19.81
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Volume: 631400
Market Capitalization: 735.8 million